Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions

The development of novel therapies against melanoma would benefit from individualized tumor models to ensure the rapid and accurate identification of biomarkers of therapy response. Previous studies have suggested that patient-derived xenografts (PDXes) could be useful. However, the utility of PDXes...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Einarsdottir, Berglind O., Bagge, Roger Olofsson, Bhadury, Joydeep, Jespersen, Henrik, Mattsson, Jan, Nilsson, Lisa M., Truvé, Katarina, López, Marcela Dávila, Naredi, Peter, Nilsson, Ola, Stierner, Ulrika, Ny, Lars, Nilsson, Jonas A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2014
Ämnen:
Clinical Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259423/
https://ncbi.nlm.nih.gov/pubmed/25228592
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk